Clinical Trials Browser

Neoplasm Metastasis × sintilimab × Head & Neck × Clear all

NCT07581821 2026-05-12

Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal Carcinoma

Phase 2 Recruiting

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT05136768 2021-11-29

LM-HNSCC

Phase 2 Unknown

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis